Funds holding Spyre Therapeutics, Inc.
ISIN US007CVR0207 · United States · LEI 52990017AIJPRH3HQH40
- Fund holders
- 1
- Of which ETFs
- 0 1 other fund
- Value held
- 237.1K $
- Share of capital
- 0.0 % of 88.2M shares on Jul 28, 2026
A single tracked fund declares this company. So these figures do not say who owns it.
This issuer has other securities : Spyre Therapeutics Inc (US00773J2024)
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 4,700 | 237.1K $ | 0.01 % | 0.01 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.01 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 1 | 0 | 4,700 | 0.0 % |
| 2026Q1 | 1 | 0 | 4,700 | 0.0 % |
| 2025Q4 | 1 | 4,700 |
Cite this page
Titelia. "Funds holding Spyre Therapeutics, Inc.". https://titelia.com/en/stocks/spyre-therapeutics-inc-US007CVR0207